Todd C. Brady, President and CEO at Aldeyra Therapeutics, Inc. (ALDX), bought 17,700 shares at $3.36 ($59K) on 2022-06-23, disclosed to the SEC on 2022-06-27.
High-signal trade — passes our conviction filters but the AI narrative is still being generated. Check back shortly.
Something here stands out, but not much.
| Filing → |
| ALDX | BUY | 2019-12-18 | $102K | — | Filing → |
| ALDX | BUY | 2019-10-02 | $49K | — | Filing → |
| ALDX | BUY | 2019-09-25 | $101K | — | Filing → |